Document 1047 DOCN M94A1047 TI The effect of micronutrient intake on survival in HIV-1 infection. DT 9412 AU Tang AM; Graham NM; Saah AJ; Johns Hopkins School of Public Health, Baltimore, MD. SO Int Conf AIDS. 1994 Aug 7-12;10(2):220 (abstract no. PB0894). Unique Identifier : AIDSLINE ICA10/94371528 AB OBJECTIVE: This study examines the relation between dietary and supplemental micronutrient intake and subsequent mortality in participants of the Baltimore/Washington, DC site of the Multicenter AIDS Cohort Study. METHODS: Included in the study were 280 HIV-positive gay/bisexual men who completed a self-administered semiquantitative food frequency questionnaire at the baseline study visit (1984). Levels of daily micronutrient intake were examined in relation to subsequent mortality (n = 121) over the 8 year follow-up period using Kaplan-Meier survival curves and Cox proportional hazards models, adjusting for age, presence of symptoms, CD4+ lymphocyte count, energy intake, and use of antiretrovirals. RESULTS: The highest quartiles of total intake (from food and supplements) of vitamins B6 (relative hazard (RH) = 0.59, 95% confidence interval (CI) 0.37-0.93) and C (RH = 0.62, 95% CI = 0.39-0.98) were significantly associated with a decreased mortality rate. In addition, the highest quartiles of total intake of vitamins B1, B2, and niacin demonstrated a marginally significant 30-40% decrease in mortality rate. Those who took supplements at > or = 5 times the recommended dietary allowance (RDA) of vitamins B1 and B2 showed a significantly decreased rate of progression to death: vitamin B1 (RH = 0.57, 95% CI = 0.34-0.96) and vitamin B2 (RH = 0.58, 95% CI = 0.34-0.98). Those taking vitamin B6 supplements at only > or = 2 times the RDA showed a similar beneficial effect (RH = 0.59, 95% CI = 0.37-0.96). CONCLUSIONS: We have found that high intakes of several nutrients (vitamins B1, B2, B6, C, and niacin) are associated with decreased mortality rates and increase 70th percentile survival times by 205 days (B1) to 591 days (B6). Much of the protective effect appeared to be due to the intake of supplements. DE Acquired Immunodeficiency Syndrome/*DRUG THERAPY/*MORTALITY Human *HIV-1 Niacin/THERAPEUTIC USE Riboflavin/THERAPEUTIC USE Survival Rate Thiamine/THERAPEUTIC USE Trace Elements/*THERAPEUTIC USE MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).